Meanwhile, researchers, diagnostic developers, and manufacturers should consider evaluating alternative target proteins or adjusting test cutoffs in IgM-based serological assays to help minimize the detection of IgM signals from past infections. The gene discussed is CD40LG; the disease is infection.